» Articles » PMID: 23332977

Complications of Endovascular Treatment of Cerebral Aneurysms

Overview
Journal Eur J Radiol
Specialty Radiology
Date 2013 Jan 22
PMID 23332977
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The number of neuroendovascular treatments of both ruptured and unruptured aneurysms has increased substantially in the last two decades. Complications of endovascular treatments of cerebral aneurysms are rare but can potentially lead to acute worsening of the neurological status, to new neurological deficits or death. Some of the possible complications, such as vascular access site complications or systemic side effects associated with contrast medium (e.g. contrast medium allergy, contrast induced nephropathy) can also be encountered in diagnostic angiography. The most common complications of endovascular treatment of cerebral aneurysms are related to acute thromboembolic events and perforation of the aneurysm. Overall, the reported rate of thromboembolic complications ranges between 4.7% and 12.5% while the rate of intraprocedural rupture of cerebral aneurysms is about 0.7% in patients with unruptured aneurysms and about 4.1% in patients with previously ruptured aneurysms. Thromboembolic and hemorrhagic complications may occur during different phases of endovascular procedures and are related to different technical, clinical and anatomic reasons. A thorough knowledge of the different aspects of these complications can reduce the risk of their occurrence and minimize their clinical sequelae. A deep understanding of complications and of their management is thus part of the best standard of care.

Citing Articles

Intracranial hemorrhagic events associated with flow diversion treatment: a retrospective analysis from a single academic institution.

Wadhwa A, Ramirez-Velandia F, Enriquez-Marulanda A, Filo J, Fodor T, Sconzo D Neurosurg Rev. 2025; 48(1):28.

PMID: 39776263 DOI: 10.1007/s10143-024-03171-9.


Analysis of selective neurocritical care admission costs following elective endovascular treatment of unruptured intracranial aneurysms.

Roth S, Ahn S, Liles C, Velagapudi L, Mummareddy N, Ko Y Interv Neuroradiol. 2024; :15910199241288880.

PMID: 39387160 PMC: 11559827. DOI: 10.1177/15910199241288880.


Stent-assisted coiling vs. coiling alone of ruptured tiny intracranial aneurysms: A contemporary cohort study in a high-volume center.

Zhang G, Wu Y, Wei Y, Xue G, Chen R, Lv N Front Neurol. 2022; 13:1076026.

PMID: 36561296 PMC: 9763558. DOI: 10.3389/fneur.2022.1076026.


Prediction and analysis of periprocedural complications associated with endovascular treatment for unruptured intracranial aneurysms using machine learning.

Tian Z, Li W, Feng X, Sun K, Duan C Front Neurol. 2022; 13:1027557.

PMID: 36313499 PMC: 9596813. DOI: 10.3389/fneur.2022.1027557.


Effectiveness of MRA on embolized intracranial aneurysms: a comparison of DSA, CE-MRA, and TOF-MRA.

Qassim A, Guan S, Ngowo H, Liu B, Xu H J Interv Med. 2021; 1(1):32-41.

PMID: 34805829 PMC: 8586576. DOI: 10.19779/j.cnki.2096-3602.2018.01.08.